27 results
·
30ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
Coapt LLC
FDA registration
Coapt LLC·3 products·🇺🇸 United States
ControlSeal Electrode Domes (Standard Size)
FDA UDI
COAPT LLC·B618E4·Non-invasive, cutaneous electrode for use with ...
Coapt Evaluation Kit
FDA UDI
COAPT LLC·B618Q1·The Coapt Evaluation Kit is a handheld clinical...
COMPLETE CONTROL System Gen2
FDA UDI
COAPT LLC·B618N1·The COMPLETE CONTROL System Gen2 is an advanced...
ControlSeal Electrode Domes (Large Size)
FDA UDI
COAPT LLC·B618E3·Non-invasive, cutaneous electrode for use with ...
ControlSeal Electrode Domes (Standard Size)
FDA UDI
COAPT LLC·B618E2·Non-invasive, cutaneous electrode for use with ...
Gen2 System Kit
FDA UDI
COAPT LLC·B618P1·The Gen2 System Kit is a medical device kit tha...
Complete Co-Amp
FDA UDI
COAPT LLC·B618C0·8-Channel EMG Front End Processing Unit
Dome Electrodes
FDA UDI
COAPT LLC·B618E0·Non-invasive, cutaneous electrode for use with ...
Complete Controller
FDA UDI
COAPT LLC·B618A0·Pattern Recognition Processing Unit
Complete Calibrate
FDA UDI
COAPT LLC·B618D0·Socket-Mount Calibration Unit
ControlSeal Electrode Domes (Standard Size)
FDA UDI
COAPT LLC·B618E1·Non-invasive, cutaneous electrode for use with ...
Complete Communicator
FDA UDI
COAPT LLC·B618B0·PC-Side Wireless Radio Receiver Unit
ControlSeal Electrode Domes (Large Size)
FDA UDI
COAPT LLC·B618E5·Non-invasive, cutaneous electrode for use with ...
Coapt Dome Electrode, Gen2 system, cutaneous electrode
FDA Recall
Open, Classified
·Coapt LLC·Product code GXY·October 2, 2023
Coapt ControlSeal Electrode, cutaneous EMG Electrode
FDA Recall
Open, Classified
·Coapt LLC·Product code GXY·October 2, 2023
COAPT DOME ELECTRODE
FDA Adverse Event
Injury
·COAPT, LLC·Product code GXY·September 19, 2023
CONTROLSEAL ELECTRODE
FDA Adverse Event
Injury
·COAPT LLC·Product code GXY·September 19, 2023
Coapt ControlSeal Electrode, cutaneous EMG Electrode
FDA Enforcement
Class II
·Ongoing·Coapt LLC·November 8, 2023
Coapt Dome Electrode, Gen2 system, cutaneous electrode
FDA Enforcement
Class II
·Ongoing·Coapt LLC·November 8, 2023